Drug Pricing at Site Level, What We’re Talking About This Week
  1. Meeting the drug pricing debate at the clinical trial site level

The inability to identify the best clinical trial sites is a big problem – and one of the major challenges negatively affecting drug pricing and sponsors, says CEO.

  1.  Why better data sharing is needed to aid cancer research

Healthcare organizations that have clinical data on cancer trials need to share that information with global researchers to advance investigations into solving the disease.

  1.  Clinical research trial investigates new treatment approach for early-stage eye melanoma

A first-of-its-kind, new option for treating a form of eye cancer is now in its first phase-1 clinical research trial at Wills Eye Hospital in Philadelphia. The treatment, called light-activated AU-011 is an investigational drug that targets and aims to selectively destroy malignant cancer cells in patients who have life-and vision-threatening eye cancer.